Pediatrix Medical Group, Inc.
MD
$21.57
-$0.55-2.49%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 492.88M | 468.84M | 458.36M | 502.36M | 511.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 492.88M | 468.84M | 458.36M | 502.36M | 511.16M |
| Cost of Revenue | 352.53M | 344.12M | 355.72M | 373.84M | 394.34M |
| Gross Profit | 140.35M | 124.73M | 102.64M | 128.53M | 116.82M |
| SG&A Expenses | 60.79M | 55.71M | 58.60M | 63.55M | 58.12M |
| Depreciation & Amortization | 5.55M | 5.31M | 5.33M | 6.87M | 6.25M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 418.87M | 405.14M | 419.65M | 444.26M | 458.71M |
| Operating Income | 74.01M | 63.70M | 38.71M | 58.10M | 52.45M |
| Income Before Tax | 87.78M | 54.97M | 28.09M | 33.33M | 25.24M |
| Income Tax Expenses | 16.07M | 15.71M | 7.35M | 2.85M | 5.79M |
| Earnings from Continuing Operations | 71.71M | 39.26M | 20.74M | 30.48M | 19.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.71M | 39.26M | 20.74M | 30.48M | 19.44M |
| EBIT | 74.01M | 63.70M | 38.71M | 58.10M | 52.45M |
| EBITDA | 79.56M | 69.01M | 44.04M | 64.97M | 58.70M |
| EPS Basic | 0.85 | 0.46 | 0.25 | 0.36 | 0.23 |
| Normalized Basic EPS | 0.54 | 0.43 | 0.26 | 0.38 | 0.33 |
| EPS Diluted | 0.84 | 0.46 | 0.24 | 0.36 | 0.23 |
| Normalized Diluted EPS | 0.53 | 0.43 | 0.25 | 0.38 | 0.32 |
| Average Basic Shares Outstanding | 84.61M | 84.80M | 84.44M | 85.16M | 83.89M |
| Average Diluted Shares Outstanding | 85.61M | 85.53M | 85.43M | 85.16M | 84.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |